EMEA-003211-PIP01-22 - paediatric investigation plan

Gold (Au)

Key facts

• Active Substance:
  Gold (Au)
• Therapeutic area:
  Neurology
• Decision number:
  P/0301/2022
• PIP number:
  EMEA-003211-PIP01-22
• Pharmaceutical form(s):
  Oral suspension
• Condition(s) / indication(s):
  Treatment of amyotrophic lateral sclerosis
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  09/08/2023

Decision

P/0301/2022 : EMA decision on 9 August 2022 on the granting of a product specific waiver for gold (Au) (EMEA-003211-PIP01-22)

AdoptedReference Number: EMA/673865/2022